| Original language | English |
|---|---|
| Pages (from-to) | 168-179 |
| Journal | European Journal of Cancer |
| Volume | 63 |
| DOIs | |
| Publication status | Published - Aug 2016 |
Keywords
- Breast cancer
- Adjuvant chemotherapy
- Cost effectiveness
- uPA/PAI-1
- Quality of life
Cite this
}
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer. / Marguet, Sophie; Mazouni, Chafika; Ramaekers, Bram L. T.; Dunant, Ariane; Kates, Ronald; Jacobs, Volker R.; Joore, Manuela A.; Harbeck, Nadia; Bonastre, Julia.
In: European Journal of Cancer, Vol. 63, 08.2016, p. 168-179.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer
AU - Marguet, Sophie
AU - Mazouni, Chafika
AU - Ramaekers, Bram L. T.
AU - Dunant, Ariane
AU - Kates, Ronald
AU - Jacobs, Volker R.
AU - Joore, Manuela A.
AU - Harbeck, Nadia
AU - Bonastre, Julia
PY - 2016/8
Y1 - 2016/8
KW - Breast cancer
KW - Adjuvant chemotherapy
KW - Cost effectiveness
KW - uPA/PAI-1
KW - Quality of life
U2 - 10.1016/j.ejca.2016.05.013
DO - 10.1016/j.ejca.2016.05.013
M3 - Article
VL - 63
SP - 168
EP - 179
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
ER -